Hepatic abnormalities identified on abdominal computed tomography at diagnosis of uveal melanoma

Archives of Ophthalmology

Volumn 128, Issue 3, 2010, Pages 319-323

  Feinstein, Eric G ^a   Marr, Brian P ^b   Winston, Corinne B ^b   Abramson, David H ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FATTY LIVER; FEMALE; HUMAN; LIVER CYST; LIVER DISEASE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREVALENCE; PRIORITY JOURNAL; UVEA MELANOMA;

ABDOMEN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 77749324392     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.401     Document Type: Article

References (38)

1. Diener-West M, Reynolds SM, Agugliaro DJ, et al; Collaborative Ocular Melanoma Study Group. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol. 2005;123(12):1639-1643.
2. Gragoudas ES, Seddon JM, Egan KM, et al. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology. 1988;95(7):992-999.
3. Diener-West M, Reynolds SM, Agugliaro DJ, et al; Collaborative Ocular Melanoma Study Group Report 23. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol. 2004;22(12):2438-2444.
4. Finger PT, Kurli M, Reddy S, Tena LB, Pavlick AC. Whole body PET/CT for initial staging of choroidal melanoma. Br J Ophthalmol. 2005;89(10):1270-1274.
5. Hicks C, Foss AJ, Hungerford JL. Predictive power of screening tests for metastasis in uveal melanoma. Eye (Lond). 1998;12(pt 6):945-948.
6. Missotten GS, Keunen JE. Screening for uveal melanoma metastasis: literature review. Bull Soc Belge Ophtalmol. 2004;294(294):13-22.
7. Shields CL, Shields JA. Ocular melanoma: relatively rare but requiring respect. Clin Dermatol. 2009;27(1):122-133.
8. Donoso LA, Berd D, Augsburger JJ, Mastrangelo MJ, Shields JA. Metastatic uveal melanoma: pretherapy serum liver enzyme and liver scan abnormalities. Arch Ophthalmol. 1985;103(6):796-798.
9. Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB. Variates of survival in metastatic uveal melanoma. J Clin Oncol. 2005;23(31):8076-8080.
10. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Höffken K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer. 1993;72(7):2219-2223.
11. Lorigan JG, Wallace S, Mavligit GM. The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients. AJR Am J Roentgenol. 1991;157(6):1279-1281.
12. Collaborative Ocular Melanoma Study Group. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report No. 15. Arch Ophthalmol. 2001;119(5):670-676.
13. Rajpal S, Moore R, Karakousis CP. Survival in metastatic ocular melanoma. Cancer. 1983;52(2):334-336.
14. Gragoudas ES, Marie Lane A. Uveal melanoma: proton beam irradiation. Ophthalmol Clin North Am. 2005;18(1):111-118, ix.
15. Char DH, Phillips T, Daftari I. Proton teletherapy of uveal melanoma. Int Ophthalmol Clin. 2006;46(1):41-49.
16. Eberhardt SC, Choi PH, Bach AM, Funt SA, Felderman HE, Hann LE. Utility of sonography for small hepatic lesions found on computed tomography in patients with cancer. J Ultrasound Med. 2003;22(4):335-346.
17. Scaife CL, Ng CS, Ellis LM, Vauthey JN, Charnsangavej C, Curley SA. Accuracy of preoperative imaging of hepatic tumors with helical computed tomography. Ann Surg Oncol. 2006;13(4):542-546.
18. Aoyama T, Mastrangelo MJ, Berd D, et al. Protracted survival after resection of metastatic uveal melanoma. Cancer. 2000;89(7):1561-1568.
19. Becker JC, Terheyden P, Kämpgen E, et al. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2. Br J Cancer. 2002;87(8):840-845.
20. Schmittel A, Scheulen ME, Bechrakis NE, et al. Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma. Melanoma Res. 2005;15(3):205-207.
21. Carrasco CH, Wallace S, Charnsangavej C, Papadopoulos NE, Patt YZ, Mavligit GM. Treatment of hepatic metastases in ocular melanoma: embolization of the hepatic artery with polyvinyl sponge and cisplatin. JAMA. 1986;255(22):3152-3154.
22. Duh EJ, Schachat AP, Albert DM, Patel SM.Long-term survival in a patient with uveal melanoma and liver metastasis. Arch Ophthalmol. 2004;122(2):285-287.
23. O'Neill PA, Butt M, Eswar CV, Gillis P, Marshall E. A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. Melanoma Res. 2006;16(3):245-248.
24. Peters S, Voelter V, Zografos L, et al. Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Ann Oncol. 2006;17(4):578-583.
25. Pyrhönen S, Hahka-Kemppinen M, Muhonen T. A promising interferon plus fourdrug chemotherapy regimen for metastatic melanoma. J Clin Oncol. 1992; 10(12):1919-1926.
26. Salmon RJ, Levy C, Plancher C, et al. Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol. 1998;24 (2):127-130.
27. Siegel R, Hauschild A, Kettelhack C, Kähler KC, Bembenek A, Schlag PM. Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma. Eur J Surg Oncol. 2007;33(5):627-632.
28. Soni S, Lee DS, DiVito J Jr, et al. Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide. J Pediatr Hematol Oncol. 2002;24 (6):488-491.
29. Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology. 1999;210(1):71-74.
30. Khalil HI, Patterson SA, Panicek DM. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology. 2005;235(3):872-878.
31. Krakora GA, Coakley FV, Williams G, Yeh BM, Breiman RS, Qayyum A. Small hypoattenuating hepatic lesions at contrast-enhanced CT: prognostic importance in patients with breast cancer. Radiology. 2004;233(3):667-673.
32. Miller FH, Butler RS, Hoff FL, Fitzgerald SW, Nemcek AA Jr, Gore RM. Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms. AJR Am J Roentgenol. 1998;171(3):643-649.
33. Oliver JH III, Baron RL, Federle MP, Jones BC, Sheng R. Hypervascular liver metastases: do unenhanced and hepatic arterial phase CT images affect tumor detection? Radiology. 1997;205(3):709-715.
34. Zeman RK, Baron RL, Jeffrey RB Jr, Klein J, Siegel MJ, Silverman PM. Helical body CT: evolution of scanning protocols. AJR Am J Roentgenol. 1998;170 (6):1427-1438.
35. Kemmerer SR, Mortele KJ, Ros PR. CT scan of the liver. Radiol Clin North Am. 1998;36(2):247-261.
36. Hopper KD, Singapuri K, Finkel A. Body CT and oncologic imaging. Radiology. 2000;215(1):27-40.
37. Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol. 1986;39(2):183-188.
38. Jones EC, Chezmar JL, Nelson RC, Bernardino ME. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. AJR Am J Roentgenol. 1992;158(3):535-539.